{
    "clinical_study": {
        "@rank": "26901", 
        "acronym": "GVHD", 
        "arm_group": {
            "arm_group_label": "CT scan with contrast", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Contrast-enhanced abdominal CT will be performed 1-2 weeks after allogeneic stem cell\n      transplant, and radiographic evidence of mucosal inflammation will be correlated with the\n      subsequent development of acute graft versus host disease.  The primary endpoint is the\n      feasibility and safety of contrast-enhanced abdominal CT in the early post-transplant\n      period, as defined by the risk of contrast-related nephropathy or allergic reaction."
        }, 
        "brief_title": "Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Myelodysplastic Syndromes", 
            "Leukemia, Myeloid, Acute", 
            "Leukemia, Myelogenous, Chronic", 
            "Multiple Myeloma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Graft vs Host Disease", 
                "Leukemia", 
                "Leukemia, Myeloid, Acute", 
                "Leukemia, Myeloid", 
                "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
                "Multiple Myeloma", 
                "Neoplasms, Plasma Cell", 
                "Myelodysplastic Syndromes", 
                "Preleukemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Biopsy-proven diagnosis of a hematologic malignancy\n\n          -  Scheduled to undergo allogeneic SCT from a matched sibling donor or an unrelated\n             donor who is 10/10 or 9/10 HLA match. Transplant eligibility is per standard and\n             institutional criteria.\n\n          -  Age 18-60 years\n\n          -  Willing and able to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Documented or reported contrast allergy\n\n          -  Estimated glomerular filtration rate (GFR) < 60\n\n          -  Deemed too sick by clinician to leave the floor for imaging\n\n          -  \"Nothing-per-mouth\" status for other clinical reasons\n\n        Inclusion of Women and Minorities\n\n        -Both men and women and members of all races and ethnic groups are eligible for this\n        trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02117115", 
            "org_study_id": "201404063"
        }, 
        "intervention": {
            "arm_group_label": "CT scan with contrast", 
            "description": "CT scan performed between Day +7 and Day +14.", 
            "intervention_name": "Computed Tomography", 
            "intervention_type": "Device", 
            "other_name": "CT scan with contrast"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 16, 2014", 
        "link": {
            "description": "Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine", 
            "url": "http://www.siteman.wustl.edu"
        }, 
        "location": {
            "contact": {
                "email": "acashen@dom.wustl.edu", 
                "last_name": "Amanda Cashen, M.D.", 
                "phone": "314-454-8491"
            }, 
            "facility": {
                "address": {
                    "city": "St. Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63110"
                }, 
                "name": "Washington University School of Medicine"
            }, 
            "investigator": [
                {
                    "last_name": "Armin Rashidi, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Micheal Lin, M.D.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Early Post-transplant Contrast-enhanced Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation", 
        "overall_contact": {
            "email": "acashen@dom.wustl.edu", 
            "last_name": "Amanda Cashen, M.D.", 
            "phone": "314-454-8491"
        }, 
        "overall_official": {
            "affiliation": "Washington University School of Medicine", 
            "last_name": "Amanda Cashen, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Abdominal CT risk of contrast related nephropathy or allergic reaction", 
            "safety_issue": "Yes", 
            "time_frame": "180 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02117115"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "2 x 2 chi-squared test (CT score 0-1 vs. 2-3 and presence vs. absence of acute GVHD)", 
            "measure": "Correlation between CT risk scores and occurrence of acute GVHD", 
            "safety_issue": "Yes", 
            "time_frame": "180 days"
        }, 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}